Le Plessis Robinson, France

Khelil Slimani


 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Khelil Slimani: Pioneer in Injectable Biomaterials

Khelil Slimani, located in Le Plessis Robinson, France, is an innovative inventor known for his significant contributions to the field of biomaterials. With one patent to his name, Slimani is at the forefront of developing advanced medical applications.

Latest Patents

Khelil Slimani's notable patent revolves around an injectable biomaterial. This invention encompasses a non-aqueous solvent suitable for injection into human beings, combined with nanoparticles made of a polymer that is both insoluble in water and the non-aqueous solvent. Notably, these nanoparticles are loaded with a drug or biological agent, making the injectable biomaterial particularly useful for occluding normal or malformative blood vessels, non-circulating cavities, or for the necrosis of tumors. This innovation holds immense potential in the medical field, offering avenues for more effective treatments.

Career Highlights

Currently, Khelil Slimani is affiliated with Assistance Publique-Hôpitaux de Paris, where he leverages his expertise in the realm of biomaterials. His work contributes to the hospital's mission of providing cutting-edge medical solutions and demonstrates his commitment to advancing healthcare technology.

Collaborations

Throughout his career, Slimani has collaborated with talented professionals such as Minh Tam Baylatry and Anouk Bisdorf-Bresson. These partnerships highlight the importance of teamwork in the research and development process, further enhancing the innovation landscape in which Slimani operates.

Conclusion

Khelil Slimani exemplifies the spirit of innovation through his work on injectable biomaterials. His patent not only represents a significant technological advancement but also underscores his dedication to improving medical treatments. As he continues to collaborate with fellow researchers and contribute to the field, Slimani's work will undoubtedly leave a lasting impact in the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…